n-tert-butyl-n-[(e)-phenylmethylene]amine oxide structure
|
Common Name | n-tert-butyl-n-[(e)-phenylmethylene]amine oxide | ||
---|---|---|---|---|
CAS Number | 3376-24-7 | Molecular Weight | 177.243 | |
Density | 1.0±0.1 g/cm3 | Boiling Point | 283.3±23.0 °C at 760 mmHg | |
Molecular Formula | C11H15NO | Melting Point | 71-75ºC | |
MSDS | Chinese USA | Flash Point | 118.5±15.4 °C |
Use of n-tert-butyl-n-[(e)-phenylmethylene]amine oxideN-tert-Butyl-α-phenylnitrone is a nitrone-based free radical scavenger that forms nitroxide spin adducts. N-tert-Butyl-α-phenylnitrone inhibits COX2 catalytic activity. N-tert-Butyl-α-phenylnitrone has potent ROS scavenging, anti-inflammatory, neuroprotective, anti-aging and anti-diabetic activities, and can penetrate the blood-brain barrier[1][2][3][4]. |
Name | N-TERT-BUTYL-α-PHENYLNITRONE |
---|---|
Synonym | More Synonyms |
Description | N-tert-Butyl-α-phenylnitrone is a nitrone-based free radical scavenger that forms nitroxide spin adducts. N-tert-Butyl-α-phenylnitrone inhibits COX2 catalytic activity. N-tert-Butyl-α-phenylnitrone has potent ROS scavenging, anti-inflammatory, neuroprotective, anti-aging and anti-diabetic activities, and can penetrate the blood-brain barrier[1][2][3][4]. |
---|---|
Related Catalog | |
Target |
COX-2 Reactive oxygen species (ROS) |
In Vitro | N-tert-Butyl-α-phenylnitrone (PBN) (25-100 µM) treatment leads to a significant decrease in 2,2'-azobis (2-amidinopropane) dihydrochloride (AAPH)-induced intracellular ROS accumulation. N-tert-Butyl-α-phenylnitrone also attenuates AAPH-induced cytotoxicity, matrix degradation, and apoptosis. N-tert-Butyl-α-phenylnitrone suppresses AAPH-induced activation of ERK/MAPK pathway. N-tert-Butyl-α-phenylnitrone has the potenial for intervertebral disc degeneration (IDD) research[1]. |
In Vivo | N-tert-Butyl-α-phenylnitrone (PBN; 100 mg/kg; intraperitoneal injection; twice a day; C57Bl/6 mice) treatment not only abolishes the LPS-induced lipid peroxidation, nitrotyrosine residue levels, and GSH depletion, but also decreases the incidence of external malformations[2]. Animal Model: C57Bl/6 mice induced by lipopolysaccharide (LPS)[2] Dosage: 100 mg/kg Administration: Intraperitoneal injection; twice a day (on gestational day 8) Result: Abolished LPS-induced lipid peroxidation, nitrotyrosine residues, and GSH depletion. |
References |
Density | 1.0±0.1 g/cm3 |
---|---|
Boiling Point | 283.3±23.0 °C at 760 mmHg |
Melting Point | 71-75ºC |
Molecular Formula | C11H15NO |
Molecular Weight | 177.243 |
Flash Point | 118.5±15.4 °C |
Exact Mass | 177.115356 |
PSA | 28.75000 |
LogP | 1.25 |
Appearance of Characters | powder | white |
Vapour Pressure | 0.0±0.6 mmHg at 25°C |
Index of Refraction | 1.552 |
Storage condition | 2-8°C |
Water Solubility | DMSO: soluble |
Precursor 10 | |
---|---|
DownStream 8 | |
HS Code | 2925290090 |
---|---|
Summary | 2925290090 other imines and their derivatives; salts thereof。Supervision conditions:None。VAT:17.0%。Tax rebate rate:9.0%。MFN tariff:6.5%。General tariff:30.0% |
The effect of normoxia and hypoxia on a prostate (PC-3) CD44/CD41 cell side fraction.
Anticancer Res. 31(2) , 487-94, (2011) It has been reported that human prostate-derived PC-3 cells that are CD44- and CD 41 (a2 B1)-positive are enriched in cancer stem cells. This study compared the effect of PC-3 cell proliferation under... |
|
Hydroxychloroquine-inhibited dengue virus is associated with host defense machinery.
J. Interferon Cytokine Res. 35(3) , 143-56, (2015) Hydroxychloroquine (HCQ) is an antimalarial drug also used in treating autoimmune diseases. Its antiviral activity was demonstrated in restricting HIV infection in vitro; however, the clinical implica... |
|
Systematic and Molecular Basis of the Antibacterial Action of Quinoxaline 1,4-Di-N-Oxides against Escherichia coli.
PLoS ONE 10 , e0136450, (2015) Quinoxaline 1,4-di-N-oxides (QdNOs) are widely known as potent antibacterial agents, but their antibacterial mechanisms are incompletely understood. In this study, the transcriptomic and proteomic pro... |
N-tert-Butyl-alpha-phenylnitrone |
phenyl t-butyl nitrone |
N-Benzylidene-tert-butylamine N-oxide,PBN,Phenyl N-t-butylnitrone |
N-tert-Butyl-α-phenylnitrone |
Styryl phenyl sulfone |
2-Phenylethenyl phenyl sulfone |
MFCD00008799 |
EINECS 222-168-6 |
N-Benzylidene-N-(2-methyl-2-propanyl)amine oxide |
N-benzylidene-tert-butylamine N-oxide |
n-tert-butyl-n-[(e)-phenylmethylene]amine oxide |
N-benzylidene-t-butylamine N-oxide |
PHENYL TRANS-STYRYL SULFONE 99 |
Azane, (1,1-dimethylethyl)(phenylmethylene)-, oxide |